Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150046/S006

Nevisense

Scibase AB · Decision date Dec 15, 2025

FDA DECISIONP150046/S006

What did the FDA decide?

FDA records P150046/S006 as a supplement to PMA P150046, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 15, 2025.

FDA approval order statement

approval for an automated electrical test station and data acquisition process for quality testing of finished disposable Nevisense electrodes, while retaining the existing manual electrical test station and process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General, Plastic Surgery
Decision date
Dec 15, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150046/S006
Regulatory pathway
PMA supplement
Applicant
Scibase AB
Product code
ONV
Decision code
OK30
Decision date
Dec 15, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrical Impedance Spectrometer.

Applicant
Scibase AB
Product code
ONV
FDA device class
2

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P150046/S006 received

    Application receipt date recorded by FDA.

  2. P150046/S006 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150046. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150046

Product / regulatory recordCompanyPathwayDecision dateSource
NevisenseP150046/S005
Scibase ABPMA supplementFeb 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Scibase AB

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kammakargatan 22, Stockholm, SE-1140

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records